Vignesh Raman, MD, MHS
(he/him)
- Thoracic Surgery
About
Dr. Raman was born and raised in Singapore and San Diego. He graduated summa cumma laude with departmental honors in biochemistry and cell biology at UCSD and completed his medical education at Dartmouth College. He did his general surgery and thoracic surgery training at Duke University prior to his faculty appointment at UCLA.
Dr. Raman is passionate about the spectrum of thoracic surgical problems. He provides patients with care that centers their dignity, is rooted in empathy, and founded on the latest knowledge and techniques in the field. His research, with over 100 publications and 35 presentations in national and international conferences, improves how we care for patients with cancer using an array of translational and clinical research techniques and trials. He is also a Deputy Statistical Editor for the Journal of Thoracic and Cardiovascular Surgery and on the editorial board of Nature Scientific Reports.
In his free time, he enjoys cooking, hiking, and traveling with his family, including two rescue dogs. He also loves reading literary fiction from around the world. He is fluent in Tamil, his mother tongue, and English.
Languages
Education
Fellowship
Residency
Internship
Degrees
Locations
Hospital Affiliations
Ronald Reagan UCLA Medical Center
UCLA Santa Monica Medical Center
Medical Services
Areas of Focus
Research
Interests
Dr. Raman employs both translational and clinical approaches to study the gamut of chest malignancies including lung cancer, esophageal cancer, and mesothelioma. His work strives to expand our knowledge of why and how cancer occurs and spreads, tailor existing therapies and develop new therapies for patients with cancer, and ensure patients access and receive the best care possible.
His specific interests are:
- Genomics and transcriptomics-based approaches to high grade lung neuroendocrine tumors including large cell lung neuroendocrine cancer
- Clinical and genomics-based research about sublobar vs. lobar resection in lung cancer
- ‘Liquid biopsy’ and translational tools for biomarker discovery and development in lung and esophageal cancer
- The use of registry-based data and complex regression strategies to improve the level of evidence in cancer guidelines in lung and esophageal cancer
- Health equity and access to lung cancer screening
Publications
Pubmed Indexed Publications:
https://www.ncbi.nlm.nih.gov/myncbi/vignesh.raman.1/bibliography/public/
Key Publications:
Raman V, Voigt SL, Jawitz OK, Farrow NE, Rhodin KE, Yang CJ, Tong BC, D'Amico TA, Harpole DH. The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma: A Dual Registry Analysis. Ann Surg. 2023 Mar 1;277(3):e648-e656. doi: 10.1097/SLA.0000000000004976. Epub 2021 Jun 4. PubMed PMID: 34091506
Raman V, Jawitz OK, Cerullo M, Voigt SL, Rhodin KE, Yang CJ, D'Amico TA, Harpole DH, Kelsey CR, Tong BC. Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung Cancer. Ann Surg. 2022 Dec 1;276(6):e1000-e1007. doi: 10.1097/SLA.0000000000004730. Epub 2021 Jan 7. PubMed PMID: 33417330
Raman V, Jawitz OK, Farrow NE, Voigt SL, Rhodin KE, Yang CJ, Turner MC, D'Amico TA, Harpole DH, Tong BC. The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. Ann Surg. 2022 Mar 1;275(3):e562-e567. doi: 10.1097/SLA.0000000000004150. PubMed PMID: 32649467; PubMed Central PMCID: PMC7790855
Raman V, Jawitz OK, Yang CJ, Voigt SL, D'Amico TA, Harpole DH, Tong BC. The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer. J Thorac Cardiovasc Surg. 2021 Apr;161(4):1484-1492.e5. doi: 10.1016/j.jtcvs.2020.02.135. Epub 2020 Mar 22. PubMed PMID: 32327184; PubMed Central PMCID: PMC7508943
Raman V, Jawitz OK, Voigt SL, Rhodin KE, D'Amico TA, Harpole DH, Jeffrey Yang CF, Tong BC. The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer. Chest. 2021 Jan;159(1):390-400. doi: 10.1016/j.chest.2020.06.066. Epub 2020 Jul 8. PubMed PMID: 32652096; PubMed Central PMCID: PMC7856530
Voigt SL*, Raman V*, Jawitz OK, Bishawi M, Yang CJ, Tong BC, D'Amico TA, Harpole DH. The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma-An Institutional and National Analysis. J Natl Cancer Inst. 2020 Nov 1;112(11):1118-1127. doi: 10.1093/jnci/djaa002. PubMed PMID: 32011691; PubMed Central PMCID: PMC7669223
Raman V, Jawitz OK, Yang CJ, Voigt SL, Kim AW, Tong BC, D'Amico TA, Harpole DH. The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 May;159(5):2030-2040.e4. doi: 10.1016/j.jtcvs.2019.09.075. Epub 2019 Sep 30. PubMed PMID: 31706554; PubMed Central PMCID: PMC7399537
Raman V, Jawitz OK, Voigt SL, Yang CJ, Wang H, Harpole DH, D'Amico TA. Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2020 Apr;159(4):1626-1635.e1. doi: 10.1016/j.jtcvs.2019.09.123. Epub 2019 Oct 8. PubMed PMID: 31740115; PubMed Central PMCID: PMC7303510
Raman V, Jawitz OK, Yang CJ, Voigt SL, Tong BC, D'Amico TA, Harpole DH. Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer. J Thorac Oncol. 2019 Dec;14(12):2143-2151. doi: 10.1016/j.jtho.2019.09.005. Epub 2019 Sep 23. PubMed PMID: 31557535; PubMed Central PMCID: PMC7293864
Raman V, Jawitz OK, Yang CJ, Tong BC, D'Amico TA, Berry MF, Harpole DH Jr. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. Ann Thorac Surg. 2019 Aug;108(2):377-383. doi: 10.1016/j.athoracsur.2019.03.053. Epub 2019 Apr 18. PubMed PMID: 31004586; PubMed Central PMCID: PMC7282501
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.
Recognitions
Thoracic Surgery Foundation Resident Research Award (2018) for the project, 'Elucidating the Genetic Landscape of Large Cell Lung Neuroendocrine Cancer'